An approach for determination of chronopharmacokinetic parameters of methotrexate

  • K. Mansour
Article
Received:

Summary

In classical pharmacokinetic studies, the organism is represented by one or several compartments described by a system of linear differential equations with constant coefficients. A system of linear differential equations can not describe the compartmental model in the presence of chronobiological variations. The purpose of this study is to calculate the chronopharmacokinetic parameters of Methotrexate, which presents this type of variation.

Keywords

Chronobiological variations compartmental model chronopharmacokinetic parameters methotrexate 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Van Pedersen P. (1978): General treatment of linear pharmacokinetics. J. Pharm. Sci., 67, 187–191.CrossRefPubMedGoogle Scholar
  2. 2.
    Gumowski I. (1985): Drug response on intake time: mathematical analysis. Bull. groupe d’études rythmes Biol., 17, 53–66.Google Scholar
  3. 3.
    Becquet H. (1987): Modélisation pour une chronopharmacologie. Path. Biol., 35, 937–941.Google Scholar
  4. 4.
    Mansour K. (1986): Chronotoxicité et chronopharmacocinétique du méthotrexate. Aspects théorique et expérimental chez la souris. Thèse de Doctorat No. 1763350, Université Paul Sabatier, Toulouse, France.Google Scholar
  5. 5.
    Oustrin J., Mansour K., Labat C., Malmary M.F. (1988): Chronopharmacocinétique du méthotrexate chez la souris. In: Bres J., Panis G. Eds Intérêt et limites de la pharmacocinétique en sciences et développement. Sauramps Medical, 186–195.Google Scholar
  6. 6.
    Ronald A., Herman, et al. (1989): Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients. J. Pharm. Sci., 78,Google Scholar
  7. 7.
    Monjanel S., Rigault J.P., Cano J.P., Carcassone Y., Favre R. (1979): High-dose methotrexate, preliminary evaluation of a pharmacokinetic approach. Cancer Chemother. Pharmacol., 3, 189–196.CrossRefPubMedGoogle Scholar
  8. 8.
    Jacomet Y. (1989): Pharamacocinétique. Ed. Ellipses. Tome 1, 111–116.Google Scholar
  9. 9.
    Arnold V. (1984): Equations différentielles ordinaires. Ed. Mir. 149–264.Google Scholar
  10. 10.
    Besner J.G. (1989): Variations des concentrations en fonction du mode d’administration. In: Vigot P.U.M. Ed. Traité de biopharmacie et pharmacocinétique. 219–244.Google Scholar
  11. 11.
    Labat C., Mansour K., Malmary M.F., Casanovas A.M., Oustrin J. (1986): Sur le dosage du méthotrexate, de ses impuretés et de ses métabolites par chromatographie liquide à haute performance. J. Pharm. Belg., 41, 29–34.PubMedGoogle Scholar
  12. 12.
    Cal J.C., Dorian C., Cambar J. (1985): Circadian and circannual changes in nephrotoxic effect of heavy metals and antibiotics. Annu. Rev. Chronopharmacol., 2, 143–176.Google Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • K. Mansour
    • 1
  1. 1.Unité de Recherche en Sciences MédicalesInstitut National d’Enseignement supérieur en Sciences Médicales de Constantine, Bon Pasteur, Chalet des pinsConstantineAlgérie

Personalised recommendations